Pharmaceutical Analysis & Statistics, July 2014 (p100)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: therapeutics, drug, cancer, more »

2971-3010 of about 19 000 reports

Purchase Reports From Reputable Market Research Publishers

United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014

United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The UAE is one of the more developed markets in the Middle East and has a strong existing healthcare infrastructure. As the UAE is aiming to introduce comprehensive ...

  • Industries : Drug and Medication
  • Countries : United Arab Emirates
Portugal Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Portugal Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: A year has passed since the EU/IMF/ECB’s rescue package was approved, and the obligations that form part of the economic adjustment programme have had, and ...

  • Industries : Generic Drug
  • Countries : Portugal
Sri Lanka Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Sri Lanka Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Although Sri Lanka is an emerging pharmaceutical industry, it boasts relatively welldeveloped healthcare infrastructure and coverage. However, Sri Lanka’s low per capita spending on medicines ...

  • Industries : Pharmaceutical
  • Countries : Sri Lanka
South Africa Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

South Africa Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Improvements in the drug approvals process and a drug pricing system indicate that regulatory conditions in South Africa have improved significantly in recent years. However, the government’s ...

  • Industries : Drug and Medication
  • Countries : South Africa
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: In response to the expected passage of key drug policy reforms in the Czech Republic, BMI has cut its projections for pharmaceutical industry growth in 2012 to 0.0%, with the prospects of lowe ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Lithuania Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Despite a more positive economic outlook, Lithuania is still considered one of the less attractive pharmaceutical industry s within Central and Eastern Europe (CEE). Factors such as difficult ...

  • Industries : Pharmaceutical
  • Countries : Lithuania
Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Our view that Greece's pharmaceutical industry is set for a decade of decline remains firmly in play. The list of challenges is sizeable: the combination of price erosion mechanisms; rapid generic ...

  • Industries : Drug and Medication
  • Countries : Greece
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The short-term outlook for the Serbian pharmaceutical industry will continue to be clouded by corruption, debts accrued by the country’s health insurance ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Slovakia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Slovakia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Despite the formation of new government in Slovakia, our contractionary outlook for the pharmaceutical industry has been maintained as key drug policy reforms ...

  • Industries : Prescription Drug
  • Countries : Slovakia (slovak Republic)
Ghana Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Ghana Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Ghana is one of the least attractive regional industry s in the Middle East and Africa (MEA), judging by our proprietary MEA Business Environment Ratings (BER) matrix. However, the country's ...

  • Industries : Drug and Medication
  • Countries : Ghana
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Full-year trade data for 2011 and Q112 has confirmed that Moldova’s pharmaceutical industry has returned to more normal growth. However, with regional economic ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: We believe the pharmaceuticals and healthcare segment may be targeted by the government's 2011 cost-containment efforts following the successful implementation of austerity measures in 2010. ...

  • Industries : Drug and Medication
  • Countries : Spain
Vietnam Pharmaceuticals and Healthcare Industry Update Quarter 3 2010

Vietnam Pharmaceuticals and Healthcare Industry Update Quarter 3 2010

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

In our Asia Pacific Business Environment Ratings (BER) matrix for Q310, Vietnam remains ranked 13th, out of 16 key regional industry s, which now include Cambodia. Despite a marginally improved score, ...

  • Industries : Pharmaceutical
  • Countries : Vietnam
Morocco Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Morocco Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Unlike many states in the Middle East and North Africa (MENA) region, Morocco does not have extensive natural oil and gas reserves. Consequently, the state's finances are stretched and there ...

  • Industries : Drug and Medication
  • Countries : Morocco
Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The government’s aim to create proper universal healthcare coverage is unlikely to be realised in the short term but would create investors’ interest in ...

  • Industries : Drug and Medication
  • Countries : Indonesia
Norway Pharmaceuticals and Healthcare Report Q3 2014

Norway Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: An ageing population and the subsequent increased consumption of high-value prescription medicines for the treatment of long-term illnesses will result in rising ...

  • Industries : Prescription Drug
  • Countries : Norway
Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: President Hugo Chavez's distortive economic policies are increasingly damaging Venezuela's attractiveness to pharmaceutical companies . The government's latest measure, which extends price controls ...

  • Industries : Drug and Medication
  • Countries : Venezuela
Chile Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Chile Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Chile’s intellectual property (IP) regime continues to be a cause of concern for the manufacturers of innovative pharmaceuticals, with the country listed ...

  • Industries : Drug and Medication
  • Countries : Chile
United States Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

United States Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The US pharmaceutical industry is entering a period of relative stagnation. Patent expiries, fewer insured patients and greater use of rebates and discounts ...

  • Industries : Drug and Medication
  • Countries : United States
Ireland Pharmaceuticals and Healthcare Report Q3 2014

Ireland Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: We anticipate further cuts to healthcare spending to come in the coming months, in the wake of an EU Commission report citing public healthcare expenditure in ...

  • Industries : Prescription Drug
  • Countries : Ireland
Europe Clinical Data Analytics In Healthcare - Growth, Trends And Forecasts (2014 - 2019)

Europe Clinical Data Analytics In Healthcare - Growth, Trends And Forecasts (2014 - 2019)

  • $ 1 150
  • Industry report
  • September 2014
  • by Mordor Intelligence LLP

Big Data is the new buzzword in Healthcare industry. Experts are now realizing its benefits and adopting different solutions as per the requirements. One such solution which is seeing a high adoption rate ...

  • Industries : Drug Discovery and Development
  • Countries : Europe
North America Clinical Data Analytics In Healthcare - Growth, Trends And Forecasts (2014 - 2019)

North America Clinical Data Analytics In Healthcare - Growth, Trends And Forecasts (2014 - 2019)

  • $ 1 150
  • Industry report
  • September 2014
  • by Mordor Intelligence LLP

Big Data is the new buzzword in Healthcare industry. Experts are now realizing its benefits and adopting different solutions as per the requirements. One such solution which is seeing a high adoption rate ...

  • Industries : Drug Discovery and Development
  • Countries : North America
Asia-Pacific Clinical Data Analytics In Healthcare - Growth, Trends And Forecasts (2014 - 2019)

Asia-Pacific Clinical Data Analytics In Healthcare - Growth, Trends And Forecasts (2014 - 2019)

  • $ 1 000
  • Industry report
  • September 2014
  • by Mordor Intelligence LLP

Big Data is the new buzzword in Healthcare industry. Experts are now realizing its benefits and adopting different solutions as per the requirements. One such solution which is seeing a high adoption rate ...

  • Industries : Drug Discovery and Development
  • Countries : Asia
Actelion Partnering 2009-2014

Actelion Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

This report provides all the information you require to better understand Actelion and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding ...

  • Industries : Therapy
Aspen Partnering 2009-2014

Aspen Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

This report provides all the information you require to better understand Aspen and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those ...

  • Industries : Therapy
Abbott Partnering 2009-2014

Abbott Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

This report provides all the information you require to better understand Abbott and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those ...

  • Industries : Therapy
Actavis Partnering 2009-2014

Actavis Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

This report provides all the information you require to better understand Actavis and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding ...

  • Industries : Therapy
Alcon Partnering 2009-2014

Alcon Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

This report provides all the information you require to better understand Alcon and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those ...

  • Industries : Therapy
Allergan Partnering 2009-2014

Allergan Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

This report provides all the information you require to better understand Allergan and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding ...

  • Industries : Therapy
Amgen Partnering 2009-2014

Amgen Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

This report provides all the information you require to better understand Amgen and its partnering interests and activities over the past seven years. One of the key aspects of partnering is finding those ...

  • Industries : Therapy

About 400 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.